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Loreto Nuovo Hospital, Naples 
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1. Introduction 
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disease 
among adults in Europe and USA. A recent consensus conference (the Montreal Consensus) 
defined GERD as "a condition which develops when the reflux of stomach contents causes 
troublesome symptoms and/or complications". Symptoms were considered to be " 
troublesome" if they adversely affected an individual's well-being. GERD can lead to both 
esophageal and non-esophageal symptoms. The most common typical symptoms of GERD 
are heartburn and regurgitation. Non-esophageal GERD symptoms include chronic 
aspiration with cough and laryngitis (Shaheen & Ransohoff, 2002). At its core, GERD is the 
failure of the antireflux barrier, allowing abnormal amounts of reflux of gastric contents into 
the esophagus (Dodds et al., 1982). The primary treatment modality for GERD is acid 
suppression therapy, in particular by use of PPI (Castell et al., 2002). However, 
consideration should be given for surgery if the following indications exist: complications of 
GERD (such as peptic stricture or Barrett's esophagus), extraesophageal manifestations 
(chest pain, pulmonary symptoms), failed medical management, or desire to discontinue 
medical treatment despite adequate symptomatic control. Minimal invasive anti-reflux 
surgery can be considered an effective GERD therapy, with its mechanical function both in 
the short and long term period. Several different ways of fashioning a total fundoplication 
lead to different outcomes. This chapter addresses the technical details of the antireflux 
technique we adopted without modifications for all patients with GERD. In particular it 
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aims to discuss the appropriate selection of patients undergoing laparoscopic fundoplication 
and the relation between  wrap and the physiology of the esophagus. In fact, selecting 
gastroesophageal reflux disease (GERD) patients for surgery on the basis of traditional pH-
monitoring or endoscopy, may be challenging, particularly if endoscopy is negative (i.e. 
NERD patient), or presenting “uncommon” GERD with clinical symptoms (Charbel et al., 
2005). Combined multichannel intraluminal impedance pH monitoring (MII-pH) is able to 
physically detect each episode of intraesophageal bolus movements, enabling identification 
of either acid or non-acid reflux episodes and thus establish the association of the reflux 
with symptoms. Since the mechanism of fundoplication is to physically block gastric 
refluxate to enter into the esophageal lumen by restoring the competence of the lower 
esophageal sphincter (LES), the routine use of MII-pH in the preoperative evaluation may 
offer objective parameters for a more accurate indication to surgery. At the same time, some 
authors assume that a total fundoplication expose the patient to a delayed transit of the 
swallowed bolus and thus to an increased risk of dysphagia, especially when a peristaltic 
dysfunction is present. However, few studies have reported the effects of total 
fundoplication on peristalsis, bolus transit and increased risk of dysphagia by means of 
objective data; this was mainly due to the exposure to radiations and a difficulty of 
completing studies by the use of combined manometry and videofluoroscopy.  
Multichannel intraluminal impedance combined with traditional esophageal manometry 
(MII-EM) provides an objective assessment of the transit and clearance of a standardized 
bolus, and to study the esophageal motility. Montenovo et al. have recently reported the 
inefficacy of preoperative use of MII and manometry to predict postoperative dysphagia of 
patients who underwent Nissen fundoplication, based on a postoperative symptom 
questionnaire. However, no pre- or postoperative evaluation of the effects of fundoplication 
on the esophageal function has been reported to date. 
We undertook the current study to evaluate by means of MII-EM and combined 24-h pH and 
multichannel intraluminal impedance (MII-pH) the impact of fundoplication on esophageal 
physiology. An objective demonstration of the impact of the total wrap on the bolus transit 
may be helpful in refining the correct indications towards partial or total antireflux wrap. 
2. Protocol study  
The study involved a consecutive cohort of patients undergoing laparoscopic total 
fundoplication for refractory GERD, with information recorded in a prospectively 
maintained database, followed up for at least one year. Surgical treatment was offered to 
PPI- refractory patients with heartburn and regurgitation as their predominant symptoms. 
Patients were considered PPI refractory if 40 mg omeprazole was insufficient for lasting 
suppression of symptoms and if, following an increase in dosage to 40 mg two or three 
times daily, symptoms recurred after return to 40 mg maintenance treatment daily. Patients 
were included in the present study if upper endoscopy had been performed before surgery, 
preoperative 24-h combined MII-pH-monitoring demonstrated pathological reflux 
condition, and objective and subjective outcome had been registered after surgery. 
From October 1st 2005 to October 1st 2010, five hundred and twenty-three consecutive 
patients (298 women and 225 men; mean age 43.7±14.5 years; range 20-65 years) were 
referred to Esophageal Pathophysiology Center of the First Division of General and 
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Gastrointestinal Surgery of the Second University of Naples for the suspicion of esophageal 
diseases. Before subjects entered the study, a specific informed consent was obtained from 
each.  
Surgery was indicated for (1) patients with GERD who were not responding to medical 
therapy or affected by “nocturnal acid break through” phenomenon; (2) patients not 
compliant with long-term medical therapy; (3) patients requiring high dosages of drugs; (4) 
patients too young for lifetime medical treatment; (5) patients performing a particular type 
of job that does not allow drugs to be taken constantly; (6) patients with atypical GERD who 
opted for surgery or bile reflux; and (7) patients who decided, in the first instance, for the 
surgical treatment of typical GERD.  
2.1 Clinical evaluation 
After a brief interview and examination to assess for the presence and severity of 
gastrointestinal symptoms and to make anthropometric measurements, all subjects 
completed a brief symptom assessment questionnaire. The questionnaire incorporated a 
visual analog scale (modified DeMeester Score) for heartburn, regurgitation, dysphagia, and 
respiratory symptoms.  
2.2 Instrumental assessment 
Preoperatively, all patients underwent upper gastrointestinal endoscopy, Combined 
Multichannel Intraluminal Impedance and Esophageal Manometry (MII-EM) and 24 hours 
Combined Multichannel Intraluminal Impedance and pH-monitoring (MII-pH), as our 
routinary preoperative assessment for patients evaluated for antireflux surgery. 
Upper gastrointestinal endoscopy was performed according to the international guidelines 
and the center’s current practice criteria that were adopted for the preoperative study of 
candidates for antireflux therapy. Reflux esophagitis was graded according to the Los 
Angeles classification, including nonerosive esophageal reflux disease. Biopsies were 
performed for the histologic confirmation of the diagnosis of Barrett esophagus or when 
dysplastic lesions were suspected; Barrett esophagus was categorized according to 
established criteria. 
2.2.1 Combined MII-EM protocol 
Each patient underwent esophageal function testing using combined MII-EM with a 
Koenigsberg 10-channel probe (Sandhill EFT catheter; Sandhill Scientific Inc., Highlands 
Ranch, CO, USA). The 4.5-mm-diameter catheter design has two circumferential solid-state 
pressure sensors at 5 and 10 cm from the tip and three unidirectional pressure sensors at 15, 
20, and 25 cm. Impedance measuring segments consisting of two rings placed 2 cm apart 
were centered at 7, 10, 15, 20, 25 from the tip. The EFT catheter was inserted transnasally 
into the esophagus up to a depth of 60 cm and the collection of impedance and pH data (30 
Hz) was initiated. Lower esophageal sphincter (LES) was identified using station pull-
through technique and the most distal sensor was placed in the high-pressure zone of the 
LES. Intraesophageal pressure sensors and impedance measuring segments were thus 
located at 5, 10, 15, 20 cm above the LES and 2, 5, 10, 15, and 20 cm above the LES, 
respectively. In the supine position, patients were given 10 swallows of 5 cc normal saline 
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and 10 swallows of 5 cc appleasauce consistency viscous material with standardized ionic 
concentration (Viscous , Sandhill Sci.), each 20–30 s apart. Normal saline was used instead 
of regular water since it has a standardized ionic concentration and provides better 
impedance changes. Double-swallowing disqualified swallows and these were repeated. 
2.2.2 Manometric parameters assessment 
Manometric parameters used to characterize swallows included (1) contraction amplitude at 
5 and 10 cm above the LES, (2) distal esophageal amplitude (DEA) as average of contraction 
amplitude at 5 and 10 cm above the LES, (3) onset velocity of esophageal contractions in the 
distal part of the esophagus (i.e., contraction velocity between 10 and 5 cm above the LES).  
During the pull-trough distance of both distal border and proximal border of LES were 
recorded, as the distance in cm from nares. The LES length was measured, as the difference 
of distal border and proximal border in cm. 
The LES residual pressure was measured as the lowest pressure (excluding respiratory 
artefacts) during swallow-induced LES relaxation, and the LES resting pressure was 
calculated as the average (mid respiratory) LES pressure over 4–5 s at the level just distal to 
the pressure inversion point.  
Swallows were classified using the traditional manometric criteria as (1) normal, if 
contraction amplitudes at 5 and 10cm above the LES were each greater than or equal to 30 
mmHg and distal onset velocity was less than 8 cm/s; (2) ineffective, if either of the 
contraction amplitudes at 5 and 10 cm above the LES was less than 30 mmHg; (3) 
simultaneous, if the contraction had a distal onset velocity greater than 8 cm/s or 
retrograde onset and amplitudes at 5 and 10 cm above the LES were each greater or equal 
to 30 mmHg.  
Diagnoses of manometric motility abnormalities were established using criteria published 
by Spechler and Castell. DES was defined as 20% or more saline swallows with contraction 
amplitude greater than or equal to 30 mmHg in both distal sites located at 5 and 10 cm 
above the LES and contraction onset velocity greater than 8 cm/s. 
2.2.3 Impedance parameters assessment 
Bolus entry at a specific level was identified by the 50% point between 3-s preswallow 
impedance baseline and impedance nadir during bolus presence. Bolus exit was determined 
as return to this 50% point on the impedance recovery curve as discussed in previous 
studies (Fass et al.,1994).  
Swallows were classified by MII as showing (1) complete bolus transit if bolus entry 
occurred at the most proximal site (20 cm above LES) and bolus exit points were recorded in 
all three distal impedance-measuring sites (i.e., 15, 10, and 5 cm above the LES) and (2) 
incomplete bolus transit if bolus exit was not identified at any of the three distal impedance 
measuring sites.  
Total bolus transit time was calculated as the time elapsed from bolus entry in the proximal 
channel 20 cm above the LES to bolus exit in the distal channel 5 cm above the LES when 
bolus exit present. 
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Diagnoses of esophageal transit abnormalities were defined as incomplete liquid transit if at 
least 30% of liquid swallows had complete bolus transit and incomplete viscous transit if at 
least 40% of viscous swallows had complete bolus transit. These values are based on data 
from 43 healthy volunteers (Tutuian et al., 2003a). 
2.2.4 Combined 24 hour ph-multichannel intraluminal impedance (MII-pH)  
Twenty-four-hour ambulatory combined pH-multichannel intraluminal impadance studies 
were performed to document the presence of GERD. A dedicated MII-pH catheter (with 
intraluminal impedance segments positioned at 3, 5, 7, 9, 15, and 17 cm above the LES; 
Sandhill Scientific Inc., Highlands Ranch, CO, USA) was placed transnasally, with the 
esophageal pH sensor positioned 5 cm above the manometrical determined LES. Patients 
were invited to signal three or more predominant symptoms that occurred during the 
recording time, every meal, and changing position in upright or in recumbent, as on the 
device and a written diary as well. This information was transmitted by the catheter into 
software integrated into the device (Sleuth System, Sandhill Scientific Inc.). MII-pH data 
were acquired and analyzed with the Bioview GERD Analysis Software (Sandhill Scientific 
Inc.). All tracings were carefully reviewed by a single investigator [S.T.] to check 
correspondence between the results of the computer evaluation and the morphology of each 
reflux episode. Meal periods and drop in pH, not related to a retrograde movement at 
impedance (i.e., swallow of acid drink), were excluded from the analysis to improve 
accuracy of the pH monitoring (Sifrim et al., 2004; Tutuian et al., 2003b). The following 
variables were assessed: (1) esophageal acid exposure calculated as percentage (%) of time 
with pH <4 (total, upright, and recumbent), (2) number and quality (acid and non-acid) of 
reflux detected at MII, and (3) Symptom Index, described according to reported parameters. 
An abnormal % of time with pH <4 in distal esophagus, a total number of refluxes detected 
at MII >73, a Symptom Index at least 50%, or the presence of two or all three were 
considered as parameters useful to indicate antireflux surgery. 
Based on the results of MII-pH, the patients were divided into positive pH monitoring 
(pH+) and negative pH monitoring groups (pH−). This latter were further divided in two 
sub-groups if the total number of reflux episodes at MII was pathologic (pH-MII+) or the 
total number of reflux episodes were negative, though the Symptom Index was positive 
(pH-MII-SI+). 
2.3 Surgical technique 
Pneumoperitoneum was induced at 12 mmHg via a Verress needle or open Hasson’s 
technique. Five trocars (one 10 mm and four 5 mm) were inserted (one transumbellical, one 
on the left and one the right emiclavear line in ipocondrium, one in epigastrium and one 
between umbellical and the left emiclavear line). A steep reverse-Trendelenburg position 
was applied. The aspirator was inserted in the epigastric trocar to retract the left liver. The 
height of the gastroesophageal junction was localized by transillumination provided by the 
endoscope. The procedure began with the section of the anterior peritoneal reflection of the 
gastroesophageal junction, the surgeon being aware to start the section of the lesser 
omentum high enough not to cut the vagal branch to the liver. To achieve this step, the 
assistant employed a Babcock grasper positioned at the anterior esophageal fat pad, which 
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was retracted downward tward the esophagus. After identification of the anterior vagal 
nerve, the gastrophrenic ligament was sectioned. The dissection was then continued from 
right to left behind the esophagus until the crura was exposed and the angle of His was 
abolished, with particular care taken to avoid injury to the posterior vagus. 
At this point, an esophageal retractor replaced the Babcock grasper, and a posterior window 
was created large enough to accommodate fashioning of the wrap. With the help provided 
by right and left steering of the aspirator, the esophagus was widely mobilized in its 
mediastinal portion until non-inflammatory periesophageal tissue was reached and the 
esophagus lay in the abdomen without tension (floppy esophagus). The cruroplasty was 
accomplished by one simple extracorporeal non-adsorbable knot; only in cases where there 
a larger defect (>4 cm) were additional sutures required. The 2-cm-long Nissen-Rossetti 
wrap was fashioned with the anterior wall of gastric fundus passed, if possible, between the 
esophagus and the posterior vagus nerve. The short gastric vessels were always preserved. 
The two gastric hemi-valves were sutured with two stitches that never incorporated the 
esophageal muscular layer. In all cases, to check the calibration of the wrap, at the end of the 
procedure we performed intraoperative manometry and an endoscopic control (A. del 
Genio et al., 1997; G. del Genio et al., 2007); whenever a pressure outside the range (20-40 
mmHg) was detected or the endoscopic vision of the wrap was not satisfactory (difficult 
passage of the endoscope through the fundoplication, superior edge of the gastric fundus 
not included into the wrap), the fundoplication was refashioned correctly. 
2.4 Post-operative assessment and follow-up 
The same pre-operative questionnaire (incorporating a visual analog scale (0–10) for 
heartburn, regurgitation, dysphagia, and chest pain) was re-administered to patients at 6 
months, 1 and 5 years after surgery. At the 1-year control patients were asked to re-
underwent to MII-EM and MII-pH and upper endoscopy when needed. 
3. Outcomes  
3.1 Patients candidate for laparoscopic total fundoplication 
Among 523 patients investigated at MII-pH, 184 patients (35.1%) had one or more MII-pH 
parameter positive and, for this reason, were submitted to Laparoscopic Nissen-Rossetti 
Fundoplication and 339 patients (64.9%) had a negative MII-pH exam. Of these,  47.2% of  
patients complained of abdominal pain, with gastritis at esophagogastroduodenoscopy and 
underwent eradication of Helicobacter pylori infection (14/47.2) and/or started PPI therapy. 
The remaining  52.7% of patients were non-responders to PPI. 
In particular, 19.7% of patients with symptoms related to the presence of hiatus hernia 
underwent laparoscopic hernia repair, hiatoplasty, and fundoplication. Twenty-three 
percent of patients complaining of extraesophageal symptoms (i.e., hoarseness, laryngitis, 
chest pain, and globus) not related to GERD were referred to otolaryngologists, 
pulmonologists, or other specialists. 
In last cases, the symptoms were suggestive for functional dyspepsia (i.e., bloating, delayed 
gastric empting), and the patients underwent further clinical–instrumental investigation 
(i.e., diisopropyl iminodiacetic acid gastric scintigraphy scanning, 24-h intragastric bile 
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monitoring with the Bilitec), and promotility agents like metocloporamide, domperidone, 
and erythromycin were started.  
Among the 184 patients, 53.3% had abnormal pH monitoring (pH+), 27.4% had a normal pH 
monitoring and a positive number of MII reflux (>73 episodes; pH-MII+), and 19.3% had a 
normal pH monitoring and number of MII reflux (<73 episodes) and a positive Symptom 
Index. Twenty-six percent of patients  were positive for all the parameters (e.g., pH-
monitoring, number of reflux >73, and Symptom Index). All of them underwent  to 
Laparoscopic Nissen-Rossetti fundoplication. 
3.2 Clinical outcomes and follow-up 
The evaluations were performed a median of 15 days (range 5-35 days) before the 
fundoplication then 6, 12 and 60 months afterward. 
The pre- and post-operative visual analog scale symptom scoring system is reported in table 1.  
 
Mean symptom score ± S.D. Pre-operative Post-operative p 
Hearthburn 2.3±0.8 0.2±0.2 <0.05 
Regurgitation 1.8±0.9 0.3±0.2 <0.05 
Dysphagia 0.3±0.5 0.4±0.1 N.S. 
Chestpain 1.6±0.8 0.3±0.2 <0.05 
Respiratory symptoms 1.1±0.9 0.3±0.1 <0.05 
Table 1. Mean Pre- and Post-operative DeMeester symptom score (modified). 
After surgery the incidence of symptoms related to reflux was statistically decreased; no 
increase in perception of dysphagia was observed.  
At 12 months, 98.3% of patients were satisfied of the procedure and expressed the will to 
undergo the same operation knowing its effects. 
Regarding side effects, among 184 patients, 1.6% of patient complained about bloating and 
hyperflatulence and 3.8% complained about transient dysphagia, totally resolved in 2 
months after surgery. All the patients did not restart taking any anti-acid drugs for 
symptoms above the wrap. 
3.3 Instrumental outcomes 
3.3.1 Manometric parameters 
At 12 months afterward surgery, mean LES resting pressure raised from the pre-operative 
value of 16.2±7.5 mmHg to 31.1±6.3 mmHg (p<0.05). LES relaxing pressure (%) wasn’t 
affected by the wrap (91.7±3.9% pre-operatively vs. 90.1±6.4% post-operatively). 
Mean wave amplitude at 5, 10, 15 and 20 cm above LES wasn’t affected by the presence of 
fundoplication, both for liquid and viscous swallows.  Also mean distal esophageal 
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amplitude (DEA), both for liquid and viscous swallows, didn’t show any significant 
variation after surgery (88.8±34.6 mmHg vs. 86.6±39.1 mmHg for liquid swallows and 
86.5±38.7 mmHg vs. 90.4±29.0 mmHg for viscous swallows). 
The mean percentage of normal, ineffective and simultaneous waves didn’t change 
significantly, both for liquid than viscous swallows.  
Detailed manometrical data are shown in table 2. 
 
 Pre-
operative 
Post-
operative 
P 
LESP (mmHg, mean ± S.D.) 20.0± 7.5 31.1 ± 6.3 <0.05 
LES % relax 91.7±3.9 92.1±6.4 N.S. 
Liquid Swallow (N=150)    
Normal 110 108 N.S. 
Ineffective 40 41 N.S. 
Simultaneous 0 1 N.S. 
Amplitude (mmHg, mean ± S.D.) at 20 cm above 
LES 
49.1±24.5 63.5±39.8 N.S. 
Amplitude (mmHg, mean ± S.D.) at 15 cm above 
LES 
49.1±20.2 44.5±17.2 N.S. 
Amplitude (mmHg, mean ± S.D.) at 10 cm above 
LES 
82.6±33.8 75.8±37.1 N.S. 
Amplitude (mmHg, mean ± S.D.) at 5 cm above 
LES 
95.5±47.0 97.6±43.3 N.S. 
DEA 88.8±34.6 86.6±39.1 N.S. 
Viscous Swallow (N=150)    
Normal 103 123 N.S. 
Ineffective 47 27 N.S. 
Simultaneous 0 0 N.S. 
Amplitude (mmHg, mean ± S.D.) at 20 cm above 
LES 
51.5±29.9 59.6±39.9 N.S. 
Amplitude (mmHg, mean ± S.D.) at 15 cm above 
LES 
44.5±24.3 45.1±23.3 N.S. 
Amplitude (mmHg, mean ± S.D.) at 10 cm above 
LES 
75.7±36.3 79±28.6 N.S. 
Amplitude (mmHg, mean ± S.D.) at 5 cm above 
LES 
97.5±48.0 101.8±36.6 N.S. 
DEA (mmHg, mean ± S.D.) 86.5±38.7 90.4±29.0 N.S. 
 
Table 2. Pre- and Post-operative Esophageal Manometry findings. 
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3.3.2 Impedance parameters 
After total fundoplication, esophageal bolus transit patterns detected at impedance were the 
followings: 
The mean percentage of complete liquid bolus transit was not influenced by surgery 
(68.8±23.1% vs 75.5±21.8%, pre- and postoperative respectively). 
The mean percentage of complete viscous bolus transit improved, raising from 64.4±25.0% 
to 86.6±15.8% (p<0.05) pre- and postoperative respectively. 
Mean total bolus transit time, both for liquid and viscous swallows, didn’t show a 
statistically significant, changing from 8.4±1.6 seconds to 9.0±1.9 seconds for liquid swallows 
and from 8.6±1.0 seconds to 9.3±1.8 seconds for viscous swallows, pre- and postoperative 
respectively. 
Detailed impedance bolus transit data are shown in table 3. 
3.3.3 MII-pH parameters 
The Nissen-Rossetti antireflux procedure produced an improvement in all categories of the 
MII-pH over the patients’ preoperative values. Esophageal acid exposure (%) of time with 
pH <4 showed a drastically reduction post-operatively in total, upright, and recumbent 
position. The overall number of GER episodes was statistically reduced in both the upright 
and recumbent positions (p<0.05). This reduction was obtained due to the postoperative 
control of both the acid (p<0.05) and nonacid (p<0.05) GER episodes (tab 4).  
Postoperatively, symptom occurrence fell considerably. None of the patients had a positive 
symptom index. The proportion of physical reflux characteristics (liquid, mixed, gas) did not 
change after surgery. 
 
 Pre-operative  Post-operative P 
Liquid Swallows (N=150)    
Complete bolus transit 123 113 N.S. 
Incomplete bolus transit 27 37 N.S. 
Total bolus transit time  
(sec, mean ± S.D.) 
8.46±1.64 9.0±1.96 N.S. 
Viscous Swallows (N=150)    
Complete bolus transit 96 130 <0.05 
Incomplete bolus transit 54 20 <0.05 
Total bolus transit time  
(sec, mean ± S.D.) 
8.6±1.0 9.3±1.8 N.S. 
Table 3. Pre- and Post-operative Bolus transit patterns at impedance 
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  Pre-operative  Post-operative p 
Total % time at pH <4  5.9±2.9  0.4±0.3  <0.05 
Upright % time at pH <4  6.5±3.5  0.7±0.8  <0.05 
Recumbent % time at pH <4  3.3±2.5  0.2±0.2  <0.05 
DeMeester Score (pH) 17.4±8.5 1.6±1.5  <0.05 
Total number of reflux (MII) 65.2±45.4  4.4±0.5  <0.05 
Upright Total number of reflux (MII) 53.1±43.0 3.1±0.5 <0.05 
Recumbent Total number of reflux (MII) 12.1±5.0 1.3±0.5  <0.05 
Total acid reflux (MII) 33.4±21.4 1.6±0.6  <0.05 
Upright Total acid reflux (MII) 26.5±21 1.3±0.6  <0.05 
Recumbent Total acid reflux (MII) 6.9±6 0.3±0.8  <0.05 
Total non acid reflux (MII) 31.8±34.1 2.8±0.3  <0.05 
Upright Total non acid reflux (MII) 26.7±34.2 1.9±0.7  <0.05 
Recumbent Total non acid reflux (MII) 5.1±3.7 0.9±0.4  <0.05 
Table 4. Pre-and post operative MII-pH findings (Mean ± S.D.) 
4. Discussion 
There are objective data to demonstrate that MII-pH used as a routine diagnostic tool for 
patient candidates for surgery provided a satisfaction rate comparable to classic pH 
monitoring. It is noteworthy that these positive results were obtained extending the 
indication to surgery in an additional 40% of patients, with negative pH monitoring (G. del 
Genio et al., 2008). In the pre-MII era, to establish the need for surgery in patients with 
negative pH monitoring was a challenging decision. 
Data on non-acid reflux episodes and a more precise symptom index correlation helps the 
surgeon to decide for an antireflux operation vs. medical treatment. Moreover, the 
possibility of following up the patients operated on by MII-pH helps the surgeons to 
distinguish a surgical failure from gastroduodenal-associated symptoms. 
From a clinical practice standpoint, we identified three useful parameters to select patients 
for antireflux surgery. The first parameter is the presence of an abnormal time of esophageal 
exposure to pH <4. This data indicates the total exposure of the mucosa of the esophagus to 
acid, and its importance is known from the standard pH monitoring. MII-pH improves the 
affordability of this parameters, living the opportunity of detecting and excluding the 
acidification due to the swallow of acid drinks (i.e., coke, lemonade, and orange juice). The 
second parameter selected is the total number of reflux episodes detected at MII. This 
parameter indicates how many times the esophageal mucosa is exposed to refluxate from 
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the stomach independently from pH. Because PPI therapy is only able to switch reflux from 
acid to non-acid without modifying the total number of reflux episodes and because the 
patients with good esophageal clearance are more likely to have negative pH monitoring 
being more rapid to clean their esophagus, we believe that to find an abnormal number of 
reflux episodes in nonresponder patients is an indicator for antireflux surgery (Mainie et al, 
2006a). This is consistent with our positive outcomes in the group of patients with negative 
pH monitoring and a positive total number of reflux episodes at MII (pH-MII+) and the fact 
that Nissen fundoplication protects against both acid and nonacid reflux (G. del Genio et al., 
2008). The last parameter, the Symptom index correlation, helps to identify those patients 
suffering from a specific symptom. In the case of a repeated disabling symptom correlated 
to reflux, a patient may be offered the opportunity of surgery knowing the chance of solving 
it, as demonstrated by our positive clinical outcomes in the pH-MII- SI+ group. short-term 
follow-up and to the absence of a control group. Furthermore, to avoid interferences in pH 
monitoring, we prefer to perform all MII-pH exams after suspension of anti-acid therapy; 
this is a not widely accepted method. Moreover, because we use MII-pH to select patients 
for surgery, the type of reflux (acid vs. non-acid) is not crucial. It is more important to have 
real quantification of GERD. 
Current gastroenterologic research investigating GERD is focused primarily on finding 
effective drugs for patients not responding to proton pump inhibitors. It is likely that a large 
portion of these patients are affected by transient lower esophageal sphincter relaxation, 
nonacid reflux episodes, or both. Currently, the most effective treatment for these patients is 
antireflux surgery. However, although the effects of fundoplication in eliminating acid 
reflux and preventing occurrences of transient lower esophageal sphincter relaxation had 
been reported, its role on nonacid reflux blocking had not been clarified. 
Our postoperative data clearly demonstrate that the antireflux wrap acts as an effective 
functional barrier capable of protecting the esophageal mucosa from both the acid and 
nonacid GER events, and that this reduction was obtained in both the upright and 
recumbent positions. This complete protective effect is not surprising. Indeed, the Nissen 
procedure increases the distal esophageal sphincter pressure to a height three times the 
preoperative levels and restores the esophagogastric junction competence (Nissen, 1956; M. 
Rossetti & Hell, 1977). There is no reason to suspect that after the  procedure for these 
patients the acid GER disappears (at pH monitoring) whereas the nonacid GER remains 
unchanged. This is consistent with the recent observation of Mainie and Castell on the 
potential worth of fundoplication for patients not responsive to a proton pump inhibitor 
with a MII-pH positive for nonacid GER (Mainie et al., 2006b). 
Furthermore, the MII-pH was a well-tolerated procedure in both the pre- and postoperative 
settings but added more information than the traditional pH monitoring (e.g., nonacid 
reflux). Therefore, we suggest its routine use for selecting and following up the candidates 
for antireflux surgery. 
If confirmed by more extensive evaluations, the data of this study may have important 
clinical implications. Because fundoplication can control also the nonacid reflux, the 
diagnostic role of MII-pH to identify the correct candidates for surgery is crucial. Indeed, a 
patient unresponsive to proton pump inhibitors with a pathologic number of nonacid reflux 
or a positive correlation of the symptoms with nonacid type GER events can be sent to 
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surgery with an objective indication. For this reason, the mean preoperative DeMeester 
score may appear surprisingly low. Moreover, the data of this study highlight the fact that 
patients not responsive to medical treatment and with a diagnosis of nonacid GER at MII-
pH need to be addressed with an antireflux procedure until new effective drugs become 
available. 
Laparoscopic total fundoplication is currently accepted as the most effective surgical 
procedure in controlling gastroesophageal reflux disease. However, in the recent past many 
authors favored the use of a partial wrap especially for patients with defective peristalsis, as 
the result of a balanced option between the potential risk of postoperative dysphagia and 
the benefit of reflux control. Later on, partial antireflux procedures reported less favorable 
outcomes in assuring a good protection from reflux at long-term follow-up (Patti et al., 2004; 
Scheffer et al., 2004; Heider et al., 2001; Bessel et al., 2000). 
Since early 1970s, our group sustained the idea that a correctly fashioned total 
fundoplication does not increase the risk of postoperative dysphagia. The technique 
included an extensive transhiatal esophageal mobilization to restore the LES into the 
abdomen; the preservation of the lesser omentum and short gastric vessels as important 
mechanisms of preventing the intratoracic migration, télescopage or rotation of the wrap; 
the routine use of intraoperative manometry and endoscopy to control of the function (i.e. 
calibration, length) and anatomy of the wrap (the passage through, height in respect of the 
cardias, and the correct geometry around the probe in reverse vision). 
This feature in controlling reflux without increasing the dysphagia is because of the elastic 
feature of the anterior gastric wall (Nissen-Rossetti), which is able to dilate when the bolus 
passes through the wrap or to increase the pressure for Laplace’s law when the gastric 
fundus is distended, preventing reflux after a meal (Code, 1968).  A practical confirmation 
can be found in achalasic patients after extended myotomy, suggesting that the total 
fundoplication itself creates an adequate barrier without impairing the bolus also when the 
peristalsis is absent and a myotomy has abolished the lower esophageal sphincter pressure 
(G. Rossetti et al., 2005).  
This assumption recently reported by postoperative clinical trials has been based only on 
postoperative clinical observation of patients with or without a defective peristalsis. We 
offer objective data to demonstrate that a total fundoplication acts as an effective functional 
barrier able to protect the esophageal mucosa from both the acid and non-acid events, 
without affecting the esophageal transit. This is possible because the postoperative 
restoration of the LES pressure preserves the mechanisms of LES relaxation, that is 
consistent with the postoperative data of unchanged peristaltic efficiency and amplitude 
above the wrap, and a preserved bolus transit time.  
When checked by semi-solid deglutition, the percentage of complete bolus transit increased. 
This is not surprising; as previously described it is most probably the consequence of a 
reduced esophagitis after the antireflux procedure that facilitates itself a better functioning 
of the esophageal body.  
This study did not investigate the esophageal function after a partial fundoplication and did 
not compare the impact of a total vs. partial wrap in impairing the transit of the bolus. 
However, because the total fundoplication is largely recognized to be superior in controlling 
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GERD, an unchanged transit progression of the bolus after the total fundoplication, 
associated to previous observations of good outcomes at long follow up in patients normal, 
defective, or absent peristalsis, support the choice of adopting the total fundoplication as a 
unique antireflux technique based on intention to treat choice. Appropriate preoperative 
investigation and a correct surgical technique are important in securing these results. 
5. Conclusions 
Laparoscopic total fundoplication achieved good outcomes and long-term patient 
satisfaction with few complications and side-effects.  
Fundoplication controls both acid and nonacid GER as measured using MII-pH.  
Appropriate preoperative investigation and a correct surgical technique are important in 
securing these results. 
MII-pH provides useful information for an objective selection of patient candidates to 
antireflux surgery. Nissen fundoplication provides excellent outcomes in patients with 
positive pH and negative pH and positive MII monitoring or Symptom Index association. 
More extensive studies are needed to definitively standardize the useful MII-pH parameters 
to select the patient to antireflux surgery. 
Total fundoplication acts as an effective functional barrier able to protect the esophageal 
mucosa from both the acid and non-acid events, without affecting the esophageal transit 
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